GCK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A1L429 | S7 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NDE8 | S7 | Sugiyama | GAGE12H | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A6NER3 | S7 | Sugiyama | GAGE12J | ______________MSWRGRsTyyWPRPRPYVQPPEMIGPM |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00571 | T156 | Sugiyama | DDX3X DBX DDX3 | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGNNCP |
| O14556 | T301 | Sugiyama | GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 | ASTGAAKAVTKVIPELKGKLtGMAFRVPTPDVSVVDLTCRL |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15523 | T154 | Sugiyama | DDX3Y DBY | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGSNCP |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O76087 | S7 | Sugiyama | GAGE7 GAGE12I GAGE7B | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| O94776 | S433 | Sugiyama | MTA2 MTA1L1 PID | ATRGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQt |
| O94776 | S496 | Sugiyama | MTA2 MTA1L1 PID | RRAARRPYAPINANAIKAECsIRLPKAAKTPLKIHPLVRLP |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95835 | T1079 | PSP | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00966 | T210 | Sugiyama | ASS1 ASS | yEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEFKKG |
| P02810 | S24 | ELM|iPTMNet|EPSD|PSP | PRH1; PRH2 | ILLSVALLAFSSAQDLDEDVsQEDVPLVISDGGDsEQFIDE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T132 | Sugiyama | ANXA1 ANX1 LPC1 | LKTPAQFDADELRAAMKGLGtDEDtLIEILAsRtNKEIRDI |
| P04083 | T145 | Sugiyama | ANXA1 ANX1 LPC1 | AAMKGLGtDEDtLIEILAsRtNKEIRDINRVYREELKRDLA |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T229 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | AstGAAKAVGKVIPELNGKLtGMAFRVPtANVsVVDLtCRL |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | T302 | Sugiyama | SSB | ALGKAKDANNGNLQLRNKEVtWEVLEGEVEKEALKKIIEDQ |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08708 | T102 | Sugiyama | RPS17 RPS17L | DNyVPEVsALDQEIIEVDPDtKEMLKLLDFGsLsNLQVtQP |
| P08708 | T22 | Sugiyama | RPS17 RPS17L | GRVRTKTVKKAARVIIEKyytRLGNDFHtNKRVCEEIAIIP |
| P08708 | T30 | Sugiyama | RPS17 RPS17L | KKAARVIIEKyytRLGNDFHtNKRVCEEIAIIPSKKLRNKI |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CL80 | S7 | Sugiyama | GAGE12F | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DSO3 | S7 | Sugiyama | GAGE4 | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10412 | T96 | Sugiyama | H1-4 H1F4 HIST1H1E | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P15259 | S189 | Sugiyama | PGAM2 PGAMM | EEIVPQIKAGKRVLIAAHGNsLRGIVKHLEGMSDQAIMELN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T224 | Sugiyama | RPS2 RPS4 | IVsAPVPKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAI |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15924 | T61 | Sugiyama | DSP | YYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDC |
| P16083 | T59 | Sugiyama | NQO2 NMOR2 | VSDLyAMNLEPRATDKDITGtLSNPEVFNyGVEtHEAyKQR |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16401 | T99 | Sugiyama | H1-5 H1F5 HIST1H1B | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | T97 | Sugiyama | H1-3 H1F3 HIST1H1D | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | T96 | Sugiyama | H1-2 H1F2 HIST1H1C | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18206 | T1118 | Sugiyama | VCL | LMQsVKETVREAEAAsIKIRtDAGFtLRWVRKTPWyQ____ |
| P18206 | T1123 | Sugiyama | VCL | KETVREAEAAsIKIRtDAGFtLRWVRKTPWyQ_________ |
| P18621 | S14 | Sugiyama | RPL17 | _______MVRysLDPENPtKsCKSRGSNLRVHFKNtRETAQ |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | S189 | Sugiyama | PGAM1 PGAMA CDABP0006 | EEIVPQIKEGKRVLIAAHGNsLRGIVKHLEGLSEEAIMELN |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20042 | T163 | Sugiyama | EIF2S2 EIF2B | DEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEELLNRV |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P21291 | T79 | Sugiyama | CSRP1 CSRP CYRP | KSCyGKKYGPKGyGyGQGAGtLstDKGEsLGIKHEEAPGHR |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T600 | Sugiyama | UBA1 A1S9T UBE1 | ARMYMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySS |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23396 | T26 | Sugiyama | RPS3 OK/SW-cl.26 | sKKRKFVADGIFKAELNEFLtRELAEDGysGVEVRVtPTRT |
| P23396 | T70 | Sugiyama | RPS3 OK/SW-cl.26 | ILATRTQNVLGEKGRRIRELtAVVQKRFGFPEGsVELyAEK |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29401 | T346 | Sugiyama | TKT | AKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIECYIAE |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | T73 | Sugiyama | EEF1D EF1D | ARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQs |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P31947 | T207 | Sugiyama | SFN HME1 | PEEAISLAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNL |
| P31948 | T145 | Sugiyama | STIP1 | MNPFNMPNLYQKLESDPRtRtLLSDPTYRELIEQLRNKPSD |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P32969 | T85 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | KELATVRTICSHVQNMIKGVtLGFRYKMRSVYAHFPINVVI |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P35268 | T62 | Sugiyama | RPL22 | FLQERIKVNGKAGNLGGGVVtIERsKSKITVTSEVPFSKRY |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T266 | Sugiyama | RPL4 RPL1 | VGRFCIWtEsAFRKLDELyGtWRKAAsLKsNyNLPMHKMIN |
| P36578 | T287 | Sugiyama | RPL4 RPL1 | WRKAAsLKsNyNLPMHKMINtDLsRILKsPEIQRALRAPRK |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | T111 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAFtADGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDP |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40939 | T117 | Sugiyama | HADHA HADH | CFIAGADINMLAACKTLQEVtQLSQEAQRIVEKLEKSTKPI |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P42858 | T3 | PSP | HTT HD IT15 | __________________MAtLEKLMKAFEsLKsFQQQQQQ |
| P46776 | T80 | Sugiyama | RPL27A | HYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPI |
| P46776 | T86 | Sugiyama | RPL27A | NQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRs |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | T80 | Sugiyama | RPL28 | VVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKN |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46940 | T1471 | Sugiyama | IQGAP1 KIAA0051 | tLQEKKEKIQTGLKKLTELGtVDPKNKyQELINDIARDIRN |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48426 | S115 | Sugiyama | PIP4K2A PI5P4KA PIP5K2 PIP5K2A | PMVFRNLRERFGIDDQDFQNsLTRSAPLPNDSQARSGARFH |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49368 | T486 | Sugiyama | CCT3 CCTG TRIC5 | LRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQTY |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49773 | T17 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | ____MADEIAKAQVARPGGDtIFGKIIRKEIPAKIIFEDDR |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55072 | T761 | Sugiyama | VCP HEL-220 HEL-S-70 | RFARRsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGA |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T205 | Sugiyama | TPI1 TPI | VHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQP |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S192 | Sugiyama | RPS3A FTE1 MFTL | MTREVQTNDLKEVVNKLIPDsIGKDIEKACQsIyPLHDVFV |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61313 | T80 | Sugiyama | RPL15 EC45 TCBAP0781 | VIyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQs |
| P61353 | S34 | Sugiyama | RPL27 | LAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVT |
| P61513 | T16 | Sugiyama | RPL37A | _____MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAK |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62314 | T57 | Sugiyama | SNRPD1 | NTHLKAVKMTLKNREPVQLEtLsIRGNNIRYFILPDsLPLD |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T144 | Sugiyama | RPL7A SURF-3 SURF3 | GKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPI |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T177 | Sugiyama | RPS4X CCG2 RPS4 SCAR | NDtIQIDLEtGKITDFIKFDtGNLCMVtGGANLGRIGVITN |
| P62701 | T184 | Sugiyama | RPS4X CCG2 RPS4 SCAR | LEtGKITDFIKFDtGNLCMVtGGANLGRIGVITNRERHPGs |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | S6 | Sugiyama | RPS6 OK/SW-cl.2 | _______________MKLNIsFPAtGCQKLIEVDDERKLRt |
| P62753 | T10 | Sugiyama | RPS6 OK/SW-cl.2 | ___________MKLNIsFPAtGCQKLIEVDDERKLRtFyEK |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62753 | T26 | Sugiyama | RPS6 OK/SW-cl.2 | sFPAtGCQKLIEVDDERKLRtFyEKRMAtEVAADALGEEWK |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62847 | S78 | Sugiyama | RPS24 | FGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYE |
| P62847 | T69 | Sugiyama | RPS24 | KTTPDVIFVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKH |
| P62851 | T110 | Sugiyama | RPS25 | ELLsKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA_____ |
| P62851 | T113 | Sugiyama | RPS25 | sKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA________ |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62888 | S102 | Sugiyama | RPL30 | GtACGKyyRVCtLAIIDPGDsDIIRsMPEQtGEK_______ |
| P62888 | T112 | Sugiyama | RPL30 | CtLAIIDPGDsDIIRsMPEQtGEK_________________ |
| P62888 | T93 | Sugiyama | RPL30 | HysGNNIELGtACGKyyRVCtLAIIDPGDsDIIRsMPEQtG |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T23 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T549 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GtNtIMDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEI |
| Q00839 | T554 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | MDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEIAARKK |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02539 | T99 | Sugiyama | H1-1 H1F1 HIST1H1A | NNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVET |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q04637 | T1119 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GGSGAKPSDAAsEAARPAtstLNRFsALQQAVPtEsTDNRR |
| Q05639 | T23 | Sugiyama | EEF1A2 EEF1AL STN | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | S30 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | HPAPNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTF |
| Q06830 | T183 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | FQFtDKHGEVCPAGWKPGsDtIKPDVQKSKEyFSKQK____ |
| Q07020 | T122 | Sugiyama | RPL18 | ALRVTSRARSRILRAGGKILtFDQLALDsPKGCGtVLLsGP |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T79 | Sugiyama | RPL18 | PPLsLsRMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07021 | T163 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | FDGEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALV |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | T1167 | Sugiyama | TJP1 ZO1 | EQAPRAsALRHEEQPAPGyDtHGRLRPEAQPHPsAGPKPAE |
| Q12851 | S170 | SIGNOR | MAP4K2 GCK RAB8IP | VKLADFGVSGELTASVAKRRsFIGtPyWMAPEVAAVERKGG |
| Q12851 | S328 | Sugiyama | MAP4K2 GCK RAB8IP | DMFPDtIHSRGQHGPAERtPsEIQFHQVKFGAPRRKEtDPL |
| Q12851 | S365 | Sugiyama | MAP4K2 GCK RAB8IP | tDPLNEPWEEEWtLLGKEELsGsLLQSVQEALEERSLtIRs |
| Q12851 | S367 | Sugiyama | MAP4K2 GCK RAB8IP | PLNEPWEEEWtLLGKEELsGsLLQSVQEALEERSLtIRsAs |
| Q12851 | S39 | Sugiyama | MAP4K2 GCK RAB8IP | LQRVGAGtyGDVYKARDtVtsELAAVKIVKLDPGDDISsLQ |
| Q12851 | S475 | Sugiyama | MAP4K2 GCK RAB8IP | ERSSCHGLPPTPKVHMGACFsKVFNGCPLRIHAAVTWIHPV |
| Q12851 | S57 | Sugiyama | MAP4K2 GCK RAB8IP | VtsELAAVKIVKLDPGDDISsLQQEItILRECRHPNVVAYI |
| Q12851 | S768 | Sugiyama | MAP4K2 GCK RAB8IP | TVVCLQDSVLAFWSHGMQGRsLDtNEVTQEITDETRIFRVL |
| Q12851 | T174 | Sugiyama | MAP4K2 GCK RAB8IP | DFGVSGELTASVAKRRsFIGtPyWMAPEVAAVERKGGYNEL |
| Q12851 | T26 | Sugiyama | MAP4K2 GCK RAB8IP | DVSLQDPRDRFELLQRVGAGtyGDVYKARDtVtsELAAVKI |
| Q12851 | T296 | Sugiyama | MAP4K2 GCK RAB8IP | QLPRALLTQLLDKASDPHLGtPsPEDCELEtyDMFPDtIHS |
| Q12851 | T313 | Sugiyama | MAP4K2 GCK RAB8IP | HLGtPsPEDCELEtyDMFPDtIHSRGQHGPAERtPsEIQFH |
| Q12851 | T326 | Sugiyama | MAP4K2 GCK RAB8IP | tyDMFPDtIHSRGQHGPAERtPsEIQFHQVKFGAPRRKEtD |
| Q12851 | T345 | Sugiyama | MAP4K2 GCK RAB8IP | RtPsEIQFHQVKFGAPRRKEtDPLNEPWEEEWtLLGKEELs |
| Q12851 | T357 | Sugiyama | MAP4K2 GCK RAB8IP | FGAPRRKEtDPLNEPWEEEWtLLGKEELsGsLLQSVQEALE |
| Q12851 | T36 | Sugiyama | MAP4K2 GCK RAB8IP | FELLQRVGAGtyGDVYKARDtVtsELAAVKIVKLDPGDDIS |
| Q12851 | T38 | Sugiyama | MAP4K2 GCK RAB8IP | LLQRVGAGtyGDVYKARDtVtsELAAVKIVKLDPGDDISsL |
| Q12851 | T63 | Sugiyama | MAP4K2 GCK RAB8IP | AVKIVKLDPGDDISsLQQEItILRECRHPNVVAYIGSYLRN |
| Q12851 | T771 | Sugiyama | MAP4K2 GCK RAB8IP | CLQDSVLAFWSHGMQGRsLDtNEVTQEITDETRIFRVLGAH |
| Q12851 | Y176 | Sugiyama | MAP4K2 GCK RAB8IP | GVSGELTASVAKRRsFIGtPyWMAPEVAAVERKGGYNELCD |
| Q12851 | Y27 | Sugiyama | MAP4K2 GCK RAB8IP | VSLQDPRDRFELLQRVGAGtyGDVYKARDtVtsELAAVKIV |
| Q12851 | Y307 | Sugiyama | MAP4K2 GCK RAB8IP | DKASDPHLGtPsPEDCELEtyDMFPDtIHSRGQHGPAERtP |
| Q12851 | Y820 | Sugiyama | MAP4K2 GCK RAB8IP | PTDNPEAHSNLYILTGHQSty____________________ |
| Q12965 | S943 | Sugiyama | MYO1E MYO1C | GLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQ |
| Q12965 | T935 | Sugiyama | MYO1E MYO1C | VLQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAA |
| Q13069 | S7 | Sugiyama | GAGE5 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13070 | S7 | Sugiyama | GAGE6 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13200 | S361 | SIGNOR|PSP | PSMD2 TRAP2 | EPKVPDDIyKtHLENNRFGGsGsQVDSARMNLASSFVNGFV |
| Q13442 | S178 | Sugiyama | PDAP1 HASPP28 | EEERKAKDDATLsGKRMQsLsLNK_________________ |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13642 | T64 | Sugiyama | FHL1 SLIM1 | RKPIGADSKEVHYKNRFWHDtCFRCAKCLHPLANEtFVAKD |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14152 | T735 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EEQRIKDMDLWEQQEEERIttMQLEREKALEHKNRMSRMLE |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14498 | T175 | Sugiyama | RBM39 HCC1 RNPC2 | VFCMQLAARIRPRDLEEFFStVGKVRDVRMISDRNSRRSKG |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q15084 | T395 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | sFsEQGINEFLRELsFGRGstAPVGGGAFPtIVEREPWDGR |
| Q15084 | T405 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | LRELsFGRGstAPVGGGAFPtIVEREPWDGRDGELPVEDDI |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16658 | T79 | Sugiyama | FSCN1 FAN1 HSN SNL | AVCLRSHLGRyLAADKDGNVtCEREVPGPDCRFLIVAHDDG |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q5VTE0 | T23 | Sugiyama | EEF1A1P5 EEF1AL3 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7Z739 | T177 | Sugiyama | YTHDF3 | YPPSSLGRAITDGQAGFGNDtLSKVPGISsIEQGMTGLKIG |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q8IVH8 | S549 | Sugiyama | MAP4K3 RAB8IPL1 | PKPISNGLPPTPKVHMGACFsKVFNGCPLKIHCASSWINPD |
| Q8IVH8 | T174 | Sugiyama | MAP4K3 RAB8IPL1 | DFGVSAQITATIAKRKsFIGtPyWMAPEVAAVERKGGYNQL |
| Q8IVH8 | Y176 | Sugiyama | MAP4K3 RAB8IPL1 | GVSAQITATIAKRKsFIGtPyWMAPEVAAVERKGGYNQLCD |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99543 | T268 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | EKQNRATRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEK |
| Q99575 | T134 | Sugiyama | POP1 KIAA0061 | EISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVKRLPRR |
| Q99575 | T189 | Sugiyama | POP1 KIAA0061 | QKKEHSKNKCHKARRCHMNRtLEFNRRQKKNIWLETHIWHA |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99832 | T458 | Sugiyama | CCT7 CCTH NIP7-1 | yAKALEIIPRQLCDNAGFDAtNILNKLRARHAQGGTWYGVD |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BUJ2 | T507 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | CLNRLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRK |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BZI7 | T153 | Sugiyama | UPF3B RENT3B UPF3X | FAPFQKAAKKKTKKRDTKVGtIDDDPEyRKFLEsyAtDNEK |
| Q9H0C5 | S273 | Sugiyama | BTBD1 C15orf1 NS5ATP8 | QRQQLPVTFGNKQKVLGKALsLIRFPLMTIEEFAAGPAQSG |
| Q9H0H5 | T251 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | EAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTE |
| Q9H0H5 | T260 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | PYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGtPQs |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NYV4 | S303 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | sAYQsstRsPsPYSRRQRsVsPYSRRRSSSYERsGsysGRs |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y295 | T62 | Sugiyama | DRG1 NEDD3 | LITPKGGGGGGPGEGFDVAKtGDARIGFVGFPSVGKSTLLS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.065540e-09 | 8.972 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.204022e-08 | 7.494 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.895005e-08 | 7.409 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.111466e-07 | 6.954 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.868261e-07 | 6.313 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.678595e-07 | 6.175 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.517570e-07 | 6.070 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.987958e-07 | 6.001 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.136679e-06 | 5.944 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.136679e-06 | 5.944 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.364603e-06 | 5.865 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.769771e-06 | 5.752 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.908795e-06 | 5.719 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.442874e-06 | 5.612 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.568356e-06 | 5.590 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.207459e-06 | 5.494 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.922925e-06 | 5.406 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.922925e-06 | 5.406 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.511683e-06 | 5.454 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.036649e-06 | 5.394 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.911289e-06 | 5.408 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.608277e-06 | 5.443 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.018468e-06 | 5.396 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.911289e-06 | 5.408 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.774190e-06 | 5.321 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.837207e-06 | 5.315 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.897123e-06 | 5.310 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.412453e-06 | 5.193 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.211030e-06 | 5.086 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.211030e-06 | 5.086 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.529558e-06 | 5.123 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.529558e-06 | 5.123 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.130499e-05 | 4.947 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.126738e-05 | 4.948 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.145706e-05 | 4.941 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.190979e-05 | 4.924 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.190979e-05 | 4.924 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.205209e-05 | 4.919 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.412335e-05 | 4.850 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.316566e-05 | 4.881 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.412335e-05 | 4.850 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.373875e-05 | 4.862 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.378659e-05 | 4.861 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.373875e-05 | 4.862 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.509426e-05 | 4.821 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.589500e-05 | 4.799 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.576206e-05 | 4.802 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.661059e-05 | 4.780 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.664748e-05 | 4.779 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.764050e-05 | 4.753 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.771071e-05 | 4.752 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.998401e-05 | 4.699 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.970842e-05 | 4.705 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.027545e-05 | 4.693 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.180577e-05 | 4.661 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.180577e-05 | 4.661 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.244774e-05 | 4.649 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.212875e-05 | 4.655 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.361287e-05 | 4.627 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.392941e-05 | 4.621 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.402169e-05 | 4.619 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.852463e-05 | 4.545 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.894223e-05 | 4.538 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.268058e-05 | 4.486 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.138531e-05 | 4.503 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.279215e-05 | 4.484 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.645696e-05 | 4.438 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.964908e-05 | 4.402 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.001574e-05 | 4.398 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.001574e-05 | 4.398 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.783421e-05 | 4.320 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.740162e-05 | 4.241 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.973203e-05 | 4.224 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.379732e-05 | 4.132 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.142651e-05 | 4.089 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.421393e-05 | 4.026 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.629838e-05 | 4.016 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.906127e-05 | 4.004 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.091368e-04 | 3.962 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.148461e-04 | 3.940 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.329335e-04 | 3.876 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.329335e-04 | 3.876 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.363213e-04 | 3.865 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.552236e-04 | 3.809 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.696702e-04 | 3.770 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.097531e-04 | 3.678 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.265778e-04 | 3.645 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.275440e-04 | 3.643 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.320043e-04 | 3.635 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.767899e-04 | 3.558 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.021911e-04 | 3.520 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.145086e-04 | 3.502 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.188068e-04 | 3.496 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.816800e-04 | 3.418 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.644678e-04 | 3.438 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.137734e-04 | 3.383 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.137734e-04 | 3.383 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.195742e-04 | 3.377 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.635142e-04 | 3.334 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.743937e-04 | 3.324 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.659674e-04 | 3.247 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.779497e-04 | 3.238 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.779497e-04 | 3.238 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.902341e-04 | 3.229 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.902341e-04 | 3.229 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.902341e-04 | 3.229 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.197581e-04 | 3.208 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.428932e-04 | 3.192 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.666219e-04 | 3.176 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.200036e-04 | 3.143 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.464668e-04 | 3.127 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.316299e-04 | 3.080 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.656611e-04 | 3.116 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.855836e-04 | 3.105 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.214488e-04 | 3.085 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.012763e-03 | 2.994 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.012763e-03 | 2.994 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.043579e-03 | 2.981 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.043579e-03 | 2.981 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.055360e-03 | 2.977 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.293687e-03 | 2.888 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.301790e-03 | 2.885 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.302307e-03 | 2.885 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.501189e-03 | 2.824 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.632685e-03 | 2.787 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.675927e-03 | 2.776 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.692047e-03 | 2.772 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.905096e-03 | 2.720 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.757354e-03 | 2.755 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.913753e-03 | 2.718 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.979751e-03 | 2.703 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.168227e-03 | 2.664 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.278806e-03 | 2.642 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.663271e-03 | 2.575 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.663271e-03 | 2.575 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.772185e-03 | 2.557 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.855788e-03 | 2.544 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.925453e-03 | 2.534 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.181630e-03 | 2.497 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.390423e-03 | 2.470 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.402851e-03 | 2.468 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.435794e-03 | 2.464 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.003780e-03 | 2.398 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.964017e-03 | 2.402 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.003780e-03 | 2.398 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.649498e-03 | 2.438 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.678228e-03 | 2.434 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.575078e-03 | 2.447 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.140824e-03 | 2.383 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.231110e-03 | 2.374 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.405372e-03 | 2.356 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.414533e-03 | 2.355 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.484464e-03 | 2.348 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.830148e-03 | 2.316 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.830148e-03 | 2.316 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.039040e-03 | 2.298 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.369305e-03 | 2.270 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.383174e-03 | 2.269 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.483866e-03 | 2.188 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.655676e-03 | 2.177 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.202511e-03 | 2.143 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.261984e-03 | 2.139 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.648975e-03 | 2.116 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.048164e-03 | 2.094 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.048164e-03 | 2.094 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.869738e-03 | 2.006 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.869738e-03 | 2.006 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.400484e-03 | 2.027 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.452921e-03 | 2.024 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.501692e-03 | 2.070 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.501692e-03 | 2.070 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.019490e-02 | 1.992 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.019490e-02 | 1.992 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.122555e-02 | 1.950 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.122555e-02 | 1.950 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.122555e-02 | 1.950 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.122555e-02 | 1.950 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.122555e-02 | 1.950 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.122555e-02 | 1.950 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.123558e-02 | 1.949 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.124583e-02 | 1.949 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.160974e-02 | 1.935 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.173418e-02 | 1.931 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.173684e-02 | 1.930 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.191128e-02 | 1.924 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.201642e-02 | 1.920 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.244976e-02 | 1.905 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.380261e-02 | 1.860 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.538025e-02 | 1.813 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.292646e-02 | 1.889 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.380261e-02 | 1.860 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.548324e-02 | 1.810 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.488724e-02 | 1.827 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.477474e-02 | 1.830 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.553106e-02 | 1.809 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.587439e-02 | 1.799 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.589719e-02 | 1.799 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.589719e-02 | 1.799 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.671288e-02 | 1.777 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.709213e-02 | 1.767 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.796577e-02 | 1.746 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.813154e-02 | 1.742 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.839792e-02 | 1.735 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.866638e-02 | 1.729 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.914695e-02 | 1.718 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.045459e-02 | 1.689 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.176031e-02 | 1.662 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.176031e-02 | 1.662 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.220481e-02 | 1.654 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.231103e-02 | 1.651 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.231103e-02 | 1.651 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.242627e-02 | 1.649 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.297226e-02 | 1.639 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.321861e-02 | 1.634 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.398641e-02 | 1.620 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.398641e-02 | 1.620 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.398641e-02 | 1.620 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.398641e-02 | 1.620 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.400692e-02 | 1.620 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.543147e-02 | 1.595 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.544843e-02 | 1.594 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.605538e-02 | 1.584 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.605538e-02 | 1.584 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.631496e-02 | 1.580 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.631496e-02 | 1.580 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.688600e-02 | 1.570 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.830823e-02 | 1.548 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.182025e-02 | 1.497 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.232817e-02 | 1.490 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.576760e-02 | 1.447 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.182025e-02 | 1.497 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.457156e-02 | 1.461 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.388227e-02 | 1.470 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.067706e-02 | 1.513 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.921412e-02 | 1.534 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.323553e-02 | 1.478 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.182025e-02 | 1.497 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.634116e-02 | 1.440 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.800931e-02 | 1.420 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 3.872714e-02 | 1.412 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 3.872714e-02 | 1.412 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 3.872714e-02 | 1.412 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.872714e-02 | 1.412 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.941043e-02 | 1.404 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.959633e-02 | 1.402 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.037570e-02 | 1.394 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.051076e-02 | 1.392 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.051076e-02 | 1.392 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.051076e-02 | 1.392 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.051076e-02 | 1.392 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.325702e-02 | 1.364 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.325702e-02 | 1.364 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.329034e-02 | 1.364 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.356121e-02 | 1.361 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.413919e-02 | 1.355 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.575135e-02 | 1.340 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.656583e-02 | 1.332 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.907616e-02 | 1.309 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.916929e-02 | 1.308 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.998006e-02 | 1.301 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.012997e-02 | 1.300 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.048000e-02 | 1.297 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.156045e-02 | 1.288 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.156045e-02 | 1.288 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.628837e-02 | 1.250 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.632309e-02 | 1.249 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.673983e-02 | 1.246 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.015500e-02 | 1.221 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.015500e-02 | 1.221 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.015500e-02 | 1.221 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.067115e-02 | 1.217 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.595675e-02 | 1.119 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.595675e-02 | 1.119 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.595675e-02 | 1.119 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.096690e-02 | 1.149 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.096690e-02 | 1.149 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.125274e-02 | 1.090 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.510561e-02 | 1.186 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.510561e-02 | 1.186 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.510561e-02 | 1.186 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.057530e-02 | 1.151 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.510561e-02 | 1.186 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.855048e-02 | 1.164 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.215552e-02 | 1.142 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.595675e-02 | 1.119 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.235136e-02 | 1.084 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.411769e-02 | 1.193 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.500486e-02 | 1.071 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.500486e-02 | 1.071 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.411769e-02 | 1.193 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.486649e-02 | 1.071 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.057530e-02 | 1.151 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.887551e-02 | 1.103 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.082873e-02 | 1.092 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.505249e-02 | 1.187 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.096690e-02 | 1.149 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.510561e-02 | 1.186 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.207657e-02 | 1.086 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.839890e-02 | 1.106 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.516477e-02 | 1.070 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.122297e-02 | 1.040 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.275502e-02 | 1.033 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.275502e-02 | 1.033 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.275502e-02 | 1.033 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.275502e-02 | 1.033 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.275502e-02 | 1.033 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.416029e-02 | 1.026 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.416029e-02 | 1.026 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.424795e-02 | 1.026 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.424795e-02 | 1.026 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.424795e-02 | 1.026 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.424795e-02 | 1.026 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.740324e-02 | 1.011 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.740324e-02 | 1.011 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.740324e-02 | 1.011 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.866100e-02 | 1.006 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.016915e-01 | 0.993 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.066001e-01 | 0.972 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.066001e-01 | 0.972 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.066001e-01 | 0.972 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.087277e-01 | 0.964 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.087277e-01 | 0.964 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.111482e-01 | 0.954 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.111482e-01 | 0.954 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.117467e-01 | 0.952 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.117467e-01 | 0.952 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.117467e-01 | 0.952 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.117467e-01 | 0.952 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.117467e-01 | 0.952 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.121586e-01 | 0.950 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.130090e-01 | 0.947 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.170857e-01 | 0.931 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.170857e-01 | 0.931 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.176429e-01 | 0.929 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.176429e-01 | 0.929 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.176429e-01 | 0.929 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.193548e-01 | 0.923 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.193548e-01 | 0.923 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.214287e-01 | 0.916 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.242984e-01 | 0.906 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.242984e-01 | 0.906 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.792276e-01 | 0.747 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.734548e-01 | 0.761 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.734548e-01 | 0.761 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.734548e-01 | 0.761 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.875404e-01 | 0.727 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.875404e-01 | 0.727 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.525655e-01 | 0.817 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.525655e-01 | 0.817 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.715107e-01 | 0.766 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.711740e-01 | 0.767 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.711740e-01 | 0.767 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.425443e-01 | 0.846 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.809927e-01 | 0.742 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.458767e-01 | 0.836 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.284903e-01 | 0.891 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.311097e-01 | 0.882 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.536955e-01 | 0.813 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.311097e-01 | 0.882 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.875404e-01 | 0.727 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.875404e-01 | 0.727 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.469534e-01 | 0.833 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.469534e-01 | 0.833 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.527041e-01 | 0.816 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.598057e-01 | 0.796 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.734548e-01 | 0.761 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.461524e-01 | 0.835 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.472227e-01 | 0.832 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.504142e-01 | 0.823 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.813601e-01 | 0.741 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.749458e-01 | 0.757 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.434969e-01 | 0.843 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.826937e-01 | 0.738 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.263872e-01 | 0.898 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.792276e-01 | 0.747 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.792276e-01 | 0.747 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.345615e-01 | 0.871 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.441223e-01 | 0.841 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.441223e-01 | 0.841 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.441223e-01 | 0.841 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.840869e-01 | 0.735 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.461524e-01 | 0.835 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.792276e-01 | 0.747 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.595543e-01 | 0.797 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.256750e-01 | 0.901 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.587801e-01 | 0.799 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.324624e-01 | 0.878 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.266618e-01 | 0.897 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.595543e-01 | 0.797 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.875404e-01 | 0.727 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.369390e-01 | 0.863 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.736585e-01 | 0.760 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.870848e-01 | 0.728 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.872018e-01 | 0.728 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.620921e-01 | 0.790 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.566217e-01 | 0.805 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.458767e-01 | 0.836 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.595543e-01 | 0.797 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 1.334781e-01 | 0.875 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.768838e-01 | 0.752 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.110234e-01 | 0.676 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.110234e-01 | 0.676 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.110234e-01 | 0.676 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.110234e-01 | 0.676 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.110234e-01 | 0.676 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.110234e-01 | 0.676 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.110234e-01 | 0.676 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.415894e-01 | 0.617 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.415894e-01 | 0.617 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.709730e-01 | 0.567 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.709730e-01 | 0.567 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.709730e-01 | 0.567 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.709730e-01 | 0.567 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.709730e-01 | 0.567 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.992199e-01 | 0.524 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.992199e-01 | 0.524 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.263740e-01 | 0.486 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.263740e-01 | 0.486 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.263740e-01 | 0.486 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.017762e-01 | 0.695 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.161293e-01 | 0.665 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.524775e-01 | 0.453 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.775710e-01 | 0.423 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.741399e-01 | 0.562 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.741399e-01 | 0.562 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.886659e-01 | 0.540 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.031571e-01 | 0.518 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.031571e-01 | 0.518 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.175946e-01 | 0.498 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.147332e-01 | 0.668 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.319608e-01 | 0.479 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.481645e-01 | 0.605 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.744768e-01 | 0.427 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.744768e-01 | 0.427 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.126667e-01 | 0.672 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.381031e-01 | 0.471 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.382633e-01 | 0.471 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.659850e-01 | 0.437 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.659850e-01 | 0.437 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.604160e-01 | 0.443 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.741399e-01 | 0.562 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.741399e-01 | 0.562 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.161293e-01 | 0.665 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.161293e-01 | 0.665 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.741399e-01 | 0.562 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.535466e-01 | 0.452 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.595999e-01 | 0.586 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.886659e-01 | 0.540 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.031571e-01 | 0.518 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.031571e-01 | 0.518 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.177191e-01 | 0.498 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.110234e-01 | 0.676 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.744768e-01 | 0.427 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.110234e-01 | 0.676 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.415894e-01 | 0.617 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.017762e-01 | 0.695 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.462395e-01 | 0.461 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.001506e-01 | 0.699 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.604160e-01 | 0.443 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.110234e-01 | 0.676 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.110234e-01 | 0.676 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.709730e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.263740e-01 | 0.486 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.775710e-01 | 0.423 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.741399e-01 | 0.562 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.775710e-01 | 0.423 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.017762e-01 | 0.695 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.305694e-01 | 0.637 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.506963e-01 | 0.601 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.215214e-01 | 0.655 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.110234e-01 | 0.676 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.415894e-01 | 0.617 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.709730e-01 | 0.567 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 2.709730e-01 | 0.567 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.263740e-01 | 0.486 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.524775e-01 | 0.453 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.775710e-01 | 0.423 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.319608e-01 | 0.479 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.314333e-01 | 0.636 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.382633e-01 | 0.471 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.738124e-01 | 0.563 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.318311e-01 | 0.635 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.886659e-01 | 0.540 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.415894e-01 | 0.617 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.844408e-01 | 0.546 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.844408e-01 | 0.546 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.462395e-01 | 0.461 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.110234e-01 | 0.676 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.263740e-01 | 0.486 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.263740e-01 | 0.486 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.775710e-01 | 0.423 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.739256e-01 | 0.562 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.215214e-01 | 0.655 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.422259e-01 | 0.616 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.088999e-01 | 0.510 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.826132e-01 | 0.549 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.001506e-01 | 0.699 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.164888e-01 | 0.500 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.161789e-01 | 0.665 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.161789e-01 | 0.665 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.110234e-01 | 0.676 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.415894e-01 | 0.617 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.709730e-01 | 0.567 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.709730e-01 | 0.567 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.524775e-01 | 0.453 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.305694e-01 | 0.637 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.775710e-01 | 0.423 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.775710e-01 | 0.423 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.844408e-01 | 0.546 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.548922e-01 | 0.594 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.997976e-01 | 0.523 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.708782e-01 | 0.431 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.300740e-01 | 0.481 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.057882e-01 | 0.515 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.111522e-01 | 0.675 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.709730e-01 | 0.567 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.010506e-01 | 0.697 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.111522e-01 | 0.675 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.775710e-01 | 0.423 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.012019e-01 | 0.696 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.526947e-01 | 0.597 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.481645e-01 | 0.605 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.057882e-01 | 0.515 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.699196e-01 | 0.432 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.996340e-01 | 0.523 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.012019e-01 | 0.696 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.056233e-01 | 0.687 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.131467e-01 | 0.671 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.951025e-01 | 0.530 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.450684e-01 | 0.611 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.110234e-01 | 0.676 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.415894e-01 | 0.617 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.415894e-01 | 0.617 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.709730e-01 | 0.567 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.992199e-01 | 0.524 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.263740e-01 | 0.486 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.263740e-01 | 0.486 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.263740e-01 | 0.486 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.524775e-01 | 0.453 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.913416e-01 | 0.536 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.280595e-01 | 0.642 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.454106e-01 | 0.610 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.951025e-01 | 0.530 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.662102e-01 | 0.436 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.370893e-01 | 0.472 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.001506e-01 | 0.699 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.747070e-01 | 0.561 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.142553e-01 | 0.669 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.415894e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.709730e-01 | 0.567 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.709730e-01 | 0.567 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.992199e-01 | 0.524 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.992199e-01 | 0.524 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.017762e-01 | 0.695 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.775710e-01 | 0.423 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.775710e-01 | 0.423 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.259534e-01 | 0.646 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.451763e-01 | 0.462 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.497225e-01 | 0.456 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.826132e-01 | 0.549 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.305694e-01 | 0.637 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.188767e-01 | 0.660 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.709730e-01 | 0.567 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.481645e-01 | 0.605 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.396969e-01 | 0.620 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.290241e-01 | 0.640 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.378998e-01 | 0.471 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.271954e-01 | 0.485 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.775710e-01 | 0.423 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.886659e-01 | 0.540 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.604160e-01 | 0.443 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.826132e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.826132e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.826132e-01 | 0.549 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.826132e-01 | 0.549 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.485937e-01 | 0.458 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.481645e-01 | 0.605 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.923289e-01 | 0.716 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.741399e-01 | 0.562 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.175946e-01 | 0.498 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.741511e-01 | 0.562 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.744768e-01 | 0.427 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.435602e-01 | 0.613 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.161293e-01 | 0.665 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.886659e-01 | 0.540 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.592695e-01 | 0.445 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.450684e-01 | 0.611 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.712910e-01 | 0.567 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.017762e-01 | 0.695 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.126667e-01 | 0.672 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.265581e-01 | 0.486 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.462395e-01 | 0.461 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.111382e-01 | 0.507 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.805370e-01 | 0.420 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.884096e-01 | 0.411 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.884096e-01 | 0.411 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.885776e-01 | 0.411 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.885776e-01 | 0.411 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.911149e-01 | 0.408 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.911149e-01 | 0.408 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.911149e-01 | 0.408 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.007614e-01 | 0.397 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.016468e-01 | 0.396 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.016935e-01 | 0.396 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.016935e-01 | 0.396 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.016935e-01 | 0.396 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.016935e-01 | 0.396 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.016935e-01 | 0.396 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.016935e-01 | 0.396 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.022033e-01 | 0.396 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.022033e-01 | 0.396 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.022033e-01 | 0.396 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.022033e-01 | 0.396 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.040056e-01 | 0.394 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.094072e-01 | 0.388 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.156863e-01 | 0.381 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.158477e-01 | 0.381 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.158477e-01 | 0.381 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.158477e-01 | 0.381 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.158477e-01 | 0.381 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.207927e-01 | 0.376 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.210228e-01 | 0.376 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.237391e-01 | 0.373 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.237391e-01 | 0.373 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.248825e-01 | 0.372 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.248825e-01 | 0.372 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.248825e-01 | 0.372 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.248825e-01 | 0.372 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.248825e-01 | 0.372 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.248825e-01 | 0.372 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.248825e-01 | 0.372 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.248825e-01 | 0.372 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.248825e-01 | 0.372 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.293337e-01 | 0.367 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.293337e-01 | 0.367 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.321081e-01 | 0.364 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.321081e-01 | 0.364 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.329061e-01 | 0.364 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.342131e-01 | 0.362 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.383824e-01 | 0.358 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.423172e-01 | 0.354 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.426531e-01 | 0.354 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.426531e-01 | 0.354 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.426531e-01 | 0.354 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.426531e-01 | 0.354 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.431953e-01 | 0.353 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.471742e-01 | 0.350 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.471742e-01 | 0.350 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.471742e-01 | 0.350 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.471742e-01 | 0.350 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.471742e-01 | 0.350 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.471742e-01 | 0.350 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.471742e-01 | 0.350 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.471742e-01 | 0.350 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.471742e-01 | 0.350 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.471742e-01 | 0.350 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.471742e-01 | 0.350 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.536041e-01 | 0.343 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.557985e-01 | 0.341 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.557985e-01 | 0.341 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.557985e-01 | 0.341 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.557985e-01 | 0.341 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.560566e-01 | 0.341 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.583807e-01 | 0.339 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.583807e-01 | 0.339 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.628968e-01 | 0.335 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.635475e-01 | 0.334 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.635475e-01 | 0.334 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.680868e-01 | 0.330 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.686031e-01 | 0.329 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.686031e-01 | 0.329 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.686031e-01 | 0.329 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.686031e-01 | 0.329 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.686031e-01 | 0.329 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.686031e-01 | 0.329 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.686031e-01 | 0.329 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.686031e-01 | 0.329 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.686031e-01 | 0.329 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.686031e-01 | 0.329 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.686031e-01 | 0.329 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.686031e-01 | 0.329 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.686031e-01 | 0.329 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.686031e-01 | 0.329 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.686031e-01 | 0.329 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.686031e-01 | 0.329 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.686031e-01 | 0.329 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.686031e-01 | 0.329 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.686031e-01 | 0.329 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.686031e-01 | 0.329 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.686031e-01 | 0.329 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.686031e-01 | 0.329 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.687635e-01 | 0.329 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.687635e-01 | 0.329 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.687635e-01 | 0.329 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.736014e-01 | 0.325 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.736014e-01 | 0.325 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.762181e-01 | 0.322 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.765384e-01 | 0.322 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.815423e-01 | 0.317 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.815423e-01 | 0.317 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.815423e-01 | 0.317 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.836889e-01 | 0.315 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.892027e-01 | 0.311 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.892027e-01 | 0.311 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.892027e-01 | 0.311 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.892027e-01 | 0.311 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.892027e-01 | 0.311 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.892027e-01 | 0.311 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.892027e-01 | 0.311 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.892027e-01 | 0.311 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.900201e-01 | 0.310 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.934441e-01 | 0.307 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.941299e-01 | 0.306 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.941299e-01 | 0.306 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.941299e-01 | 0.306 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.951805e-01 | 0.305 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.032254e-01 | 0.298 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.065218e-01 | 0.295 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.065218e-01 | 0.295 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.065218e-01 | 0.295 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.065218e-01 | 0.295 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.065218e-01 | 0.295 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.065218e-01 | 0.295 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.074945e-01 | 0.295 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.090049e-01 | 0.293 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.090049e-01 | 0.293 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.090049e-01 | 0.293 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.090049e-01 | 0.293 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.090049e-01 | 0.293 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.090049e-01 | 0.293 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.129088e-01 | 0.290 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.129088e-01 | 0.290 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.129088e-01 | 0.290 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.171255e-01 | 0.286 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.187144e-01 | 0.285 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.187144e-01 | 0.285 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.206690e-01 | 0.283 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.224911e-01 | 0.282 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.232693e-01 | 0.281 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.252785e-01 | 0.280 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.280406e-01 | 0.277 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.280406e-01 | 0.277 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.280406e-01 | 0.277 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.280406e-01 | 0.277 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.280406e-01 | 0.277 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.280406e-01 | 0.277 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.280406e-01 | 0.277 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.280406e-01 | 0.277 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.280406e-01 | 0.277 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.280406e-01 | 0.277 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.280406e-01 | 0.277 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.280406e-01 | 0.277 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.298170e-01 | 0.276 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.301223e-01 | 0.276 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.307044e-01 | 0.275 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.333646e-01 | 0.273 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.333646e-01 | 0.273 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.363275e-01 | 0.271 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.413412e-01 | 0.267 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.424894e-01 | 0.266 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.424894e-01 | 0.266 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.460685e-01 | 0.263 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.463394e-01 | 0.263 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.463394e-01 | 0.263 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.463394e-01 | 0.263 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.463394e-01 | 0.263 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.463394e-01 | 0.263 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.463394e-01 | 0.263 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.556354e-01 | 0.255 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.572020e-01 | 0.254 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.639298e-01 | 0.249 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.639298e-01 | 0.249 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.639298e-01 | 0.249 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.639298e-01 | 0.249 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.639298e-01 | 0.249 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.654358e-01 | 0.248 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.654358e-01 | 0.248 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.654358e-01 | 0.248 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.654358e-01 | 0.248 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.654358e-01 | 0.248 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.682785e-01 | 0.245 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.727248e-01 | 0.242 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.727248e-01 | 0.242 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.765945e-01 | 0.239 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.765945e-01 | 0.239 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.767644e-01 | 0.239 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.789200e-01 | 0.237 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.807572e-01 | 0.236 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.807572e-01 | 0.236 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.808391e-01 | 0.236 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.808391e-01 | 0.236 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.829273e-01 | 0.234 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.875422e-01 | 0.231 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.875422e-01 | 0.231 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.875422e-01 | 0.231 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.875422e-01 | 0.231 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.937303e-01 | 0.226 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.952098e-01 | 0.225 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.954244e-01 | 0.225 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.970938e-01 | 0.224 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.970938e-01 | 0.224 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.970938e-01 | 0.224 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.970938e-01 | 0.224 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.970938e-01 | 0.224 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.970938e-01 | 0.224 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.970938e-01 | 0.224 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.970938e-01 | 0.224 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.970938e-01 | 0.224 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 5.970938e-01 | 0.224 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.970938e-01 | 0.224 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.970938e-01 | 0.224 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.982787e-01 | 0.223 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.028297e-01 | 0.220 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.028297e-01 | 0.220 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.037780e-01 | 0.219 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.037780e-01 | 0.219 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.088037e-01 | 0.216 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.088037e-01 | 0.216 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.088037e-01 | 0.216 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.088037e-01 | 0.216 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.101526e-01 | 0.215 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.101526e-01 | 0.215 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.101526e-01 | 0.215 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.111305e-01 | 0.214 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.124521e-01 | 0.213 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.127191e-01 | 0.213 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.127191e-01 | 0.213 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.127191e-01 | 0.213 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.127191e-01 | 0.213 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.127191e-01 | 0.213 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.127191e-01 | 0.213 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.127191e-01 | 0.213 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.127191e-01 | 0.213 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.127191e-01 | 0.213 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.173919e-01 | 0.209 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.181930e-01 | 0.209 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.191176e-01 | 0.208 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.191176e-01 | 0.208 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.205513e-01 | 0.207 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.245467e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.245467e-01 | 0.204 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.277393e-01 | 0.202 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.277393e-01 | 0.202 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.277393e-01 | 0.202 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.277393e-01 | 0.202 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.277393e-01 | 0.202 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.277393e-01 | 0.202 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.277393e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.287546e-01 | 0.202 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.292208e-01 | 0.201 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.292208e-01 | 0.201 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.292208e-01 | 0.201 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.391143e-01 | 0.194 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 6.391143e-01 | 0.194 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.421779e-01 | 0.192 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.421779e-01 | 0.192 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.421779e-01 | 0.192 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.421779e-01 | 0.192 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.421779e-01 | 0.192 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.454967e-01 | 0.190 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.454967e-01 | 0.190 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.560573e-01 | 0.183 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.560573e-01 | 0.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.560573e-01 | 0.183 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.560573e-01 | 0.183 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.560573e-01 | 0.183 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.590281e-01 | 0.181 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.603327e-01 | 0.180 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 6.603327e-01 | 0.180 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.636076e-01 | 0.178 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.656617e-01 | 0.177 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.675477e-01 | 0.176 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.693991e-01 | 0.174 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.693991e-01 | 0.174 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.753766e-01 | 0.170 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.753766e-01 | 0.170 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.766149e-01 | 0.170 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.822242e-01 | 0.166 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.822242e-01 | 0.166 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.822242e-01 | 0.166 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.822242e-01 | 0.166 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.850299e-01 | 0.164 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.854798e-01 | 0.164 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.854798e-01 | 0.164 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.854798e-01 | 0.164 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.913077e-01 | 0.160 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.941444e-01 | 0.159 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.941444e-01 | 0.159 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.945525e-01 | 0.158 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.945525e-01 | 0.158 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.945525e-01 | 0.158 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.945525e-01 | 0.158 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.010760e-01 | 0.154 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.064033e-01 | 0.151 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.064033e-01 | 0.151 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.108171e-01 | 0.148 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.108817e-01 | 0.148 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.108817e-01 | 0.148 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.108817e-01 | 0.148 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.177949e-01 | 0.144 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.177949e-01 | 0.144 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.177949e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.177949e-01 | 0.144 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.177949e-01 | 0.144 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.184081e-01 | 0.144 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.189591e-01 | 0.143 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.189591e-01 | 0.143 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.241340e-01 | 0.140 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.268458e-01 | 0.139 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.268458e-01 | 0.139 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.272644e-01 | 0.138 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.272662e-01 | 0.138 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.287453e-01 | 0.137 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.287453e-01 | 0.137 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.287453e-01 | 0.137 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.287453e-01 | 0.137 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.287453e-01 | 0.137 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.287453e-01 | 0.137 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.287453e-01 | 0.137 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.322387e-01 | 0.135 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.327544e-01 | 0.135 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.345443e-01 | 0.134 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.352084e-01 | 0.134 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.383202e-01 | 0.132 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.392713e-01 | 0.131 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.392713e-01 | 0.131 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.392713e-01 | 0.131 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.392713e-01 | 0.131 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.392713e-01 | 0.131 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.392713e-01 | 0.131 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.392713e-01 | 0.131 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.392713e-01 | 0.131 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.420574e-01 | 0.130 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.432052e-01 | 0.129 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.471855e-01 | 0.127 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.493878e-01 | 0.125 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.493896e-01 | 0.125 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.493896e-01 | 0.125 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.493896e-01 | 0.125 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.493896e-01 | 0.125 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.553265e-01 | 0.122 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.565385e-01 | 0.121 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.591157e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.591157e-01 | 0.120 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.591157e-01 | 0.120 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.591157e-01 | 0.120 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.606443e-01 | 0.119 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.635123e-01 | 0.117 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.635123e-01 | 0.117 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.635123e-01 | 0.117 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.635123e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.635123e-01 | 0.117 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.684650e-01 | 0.114 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.684650e-01 | 0.114 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.684650e-01 | 0.114 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.692388e-01 | 0.114 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.726396e-01 | 0.112 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.774519e-01 | 0.109 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.774519e-01 | 0.109 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.781835e-01 | 0.109 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.824487e-01 | 0.107 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.836157e-01 | 0.106 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.840031e-01 | 0.106 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.860905e-01 | 0.105 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.860905e-01 | 0.105 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.860905e-01 | 0.105 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.860905e-01 | 0.105 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.860905e-01 | 0.105 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.860905e-01 | 0.105 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.860905e-01 | 0.105 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.889377e-01 | 0.103 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.925295e-01 | 0.101 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.943943e-01 | 0.100 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.943943e-01 | 0.100 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.943943e-01 | 0.100 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.943943e-01 | 0.100 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.943943e-01 | 0.100 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.943943e-01 | 0.100 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.958324e-01 | 0.099 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.966931e-01 | 0.099 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.018079e-01 | 0.096 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.018079e-01 | 0.096 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.023763e-01 | 0.096 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.023763e-01 | 0.096 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.023763e-01 | 0.096 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.023763e-01 | 0.096 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.023763e-01 | 0.096 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.028444e-01 | 0.095 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.048233e-01 | 0.094 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.100489e-01 | 0.091 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.120702e-01 | 0.090 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.126941e-01 | 0.090 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.132949e-01 | 0.090 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.132949e-01 | 0.090 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.132949e-01 | 0.090 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.165335e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.174240e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.174240e-01 | 0.088 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.174240e-01 | 0.088 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.174240e-01 | 0.088 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.174240e-01 | 0.088 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.174240e-01 | 0.088 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.188126e-01 | 0.087 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.188126e-01 | 0.087 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.203096e-01 | 0.086 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.232139e-01 | 0.084 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.240229e-01 | 0.084 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.241837e-01 | 0.084 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.241837e-01 | 0.084 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.245132e-01 | 0.084 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.245132e-01 | 0.084 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.245132e-01 | 0.084 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.245132e-01 | 0.084 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.245132e-01 | 0.084 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.245132e-01 | 0.084 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.245132e-01 | 0.084 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.259598e-01 | 0.083 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.276740e-01 | 0.082 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.294115e-01 | 0.081 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.294115e-01 | 0.081 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.313275e-01 | 0.080 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.313275e-01 | 0.080 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.313275e-01 | 0.080 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.313275e-01 | 0.080 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.313275e-01 | 0.080 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.320920e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.344988e-01 | 0.079 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.352810e-01 | 0.078 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.357184e-01 | 0.078 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.378777e-01 | 0.077 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.378777e-01 | 0.077 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.394488e-01 | 0.076 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.441739e-01 | 0.074 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.441739e-01 | 0.074 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.441739e-01 | 0.074 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.441739e-01 | 0.074 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.441739e-01 | 0.074 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.441739e-01 | 0.074 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.441739e-01 | 0.074 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.446899e-01 | 0.073 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.450173e-01 | 0.073 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.487033e-01 | 0.071 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.489485e-01 | 0.071 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.526263e-01 | 0.069 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.535041e-01 | 0.069 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.538451e-01 | 0.069 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.560432e-01 | 0.068 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.560432e-01 | 0.068 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.560432e-01 | 0.068 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.616349e-01 | 0.065 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.616349e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.670098e-01 | 0.062 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.670098e-01 | 0.062 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.674435e-01 | 0.062 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.695366e-01 | 0.061 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.700628e-01 | 0.060 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.721761e-01 | 0.059 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.721761e-01 | 0.059 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.721761e-01 | 0.059 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.744555e-01 | 0.058 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.771421e-01 | 0.057 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.771421e-01 | 0.057 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.771421e-01 | 0.057 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.771421e-01 | 0.057 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.783000e-01 | 0.056 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.808179e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.809325e-01 | 0.055 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.814786e-01 | 0.055 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.819154e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.819154e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.819154e-01 | 0.055 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.856651e-01 | 0.053 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.865036e-01 | 0.052 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.865036e-01 | 0.052 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.865036e-01 | 0.052 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.878151e-01 | 0.052 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.902342e-01 | 0.050 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.909138e-01 | 0.050 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.909138e-01 | 0.050 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.926157e-01 | 0.049 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.951528e-01 | 0.048 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.951528e-01 | 0.048 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.951528e-01 | 0.048 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.992274e-01 | 0.046 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.031439e-01 | 0.044 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.031439e-01 | 0.044 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.069083e-01 | 0.042 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.069083e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.105267e-01 | 0.041 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.105267e-01 | 0.041 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.105267e-01 | 0.041 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.111806e-01 | 0.040 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.111806e-01 | 0.040 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.120971e-01 | 0.040 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.139662e-01 | 0.039 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.140047e-01 | 0.039 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.167153e-01 | 0.038 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.168166e-01 | 0.038 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.173477e-01 | 0.037 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.205051e-01 | 0.036 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.205609e-01 | 0.036 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.236494e-01 | 0.034 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.243092e-01 | 0.034 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.266179e-01 | 0.033 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.267055e-01 | 0.033 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.284868e-01 | 0.032 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.294713e-01 | 0.032 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.300021e-01 | 0.032 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.312851e-01 | 0.031 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.316394e-01 | 0.031 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.322139e-01 | 0.030 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.348499e-01 | 0.029 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.348499e-01 | 0.029 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.348499e-01 | 0.029 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.357161e-01 | 0.029 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.371928e-01 | 0.028 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.373836e-01 | 0.028 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.379488e-01 | 0.028 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.398190e-01 | 0.027 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.415785e-01 | 0.026 | 0 | 0 |
| Translation | R-HSA-72766 | 9.418335e-01 | 0.026 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.420482e-01 | 0.026 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.421597e-01 | 0.026 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.430917e-01 | 0.025 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.444096e-01 | 0.025 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.452711e-01 | 0.024 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.465721e-01 | 0.024 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.486505e-01 | 0.023 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.506483e-01 | 0.022 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.535549e-01 | 0.021 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.544139e-01 | 0.020 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.561878e-01 | 0.019 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.578927e-01 | 0.019 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.578927e-01 | 0.019 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.626202e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.626202e-01 | 0.017 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.626202e-01 | 0.017 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.631640e-01 | 0.016 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.640751e-01 | 0.016 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.654736e-01 | 0.015 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.655386e-01 | 0.015 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.668176e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.673681e-01 | 0.014 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.677657e-01 | 0.014 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.698540e-01 | 0.013 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.705444e-01 | 0.013 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.727937e-01 | 0.012 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.738532e-01 | 0.012 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.757063e-01 | 0.011 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.776949e-01 | 0.010 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.802015e-01 | 0.009 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.810318e-01 | 0.008 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.814835e-01 | 0.008 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.814835e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.824268e-01 | 0.008 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.855945e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.855945e-01 | 0.006 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.866958e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.872144e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.875178e-01 | 0.005 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.877129e-01 | 0.005 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.877129e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.890949e-01 | 0.005 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.911289e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.917458e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.920678e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.923773e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.944564e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.948489e-01 | 0.002 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.956347e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.956725e-01 | 0.002 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.964655e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.966972e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.970694e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.976928e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.978697e-01 | 0.001 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.978697e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.983887e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.986801e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.986801e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.988291e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.991871e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.994548e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.996780e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.996868e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997109e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.997386e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.997621e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998263e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998970e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999335e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999523e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999625e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999838e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999931e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999987e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999993e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.330669e-16 | 15.477 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.440892e-16 | 15.353 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.663736e-15 | 14.436 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.882583e-15 | 14.103 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.881784e-15 | 14.051 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.032507e-14 | 13.986 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.398881e-14 | 13.854 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.831868e-14 | 13.737 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.996803e-14 | 13.398 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.762057e-14 | 13.239 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.227552e-14 | 13.141 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.471002e-14 | 13.072 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.493206e-14 | 13.071 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.160139e-14 | 13.088 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.320055e-13 | 12.879 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.968425e-13 | 12.706 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.704814e-13 | 12.431 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.054534e-13 | 12.392 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.074519e-13 | 12.390 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.636913e-13 | 12.178 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.558198e-12 | 11.807 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.079337e-12 | 11.682 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.944311e-12 | 11.531 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.744227e-12 | 11.427 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.923861e-12 | 11.406 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.434209e-12 | 11.265 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.294631e-12 | 11.201 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.110090e-12 | 11.148 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.231082e-12 | 11.085 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.248757e-11 | 10.904 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.210965e-11 | 10.917 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.285194e-11 | 10.891 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.429334e-11 | 10.845 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.780953e-11 | 10.749 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.810596e-11 | 10.742 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.070744e-11 | 10.684 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.301970e-11 | 10.638 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.320988e-11 | 10.634 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.504474e-11 | 10.601 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.235567e-11 | 10.490 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.411504e-11 | 10.467 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.556155e-11 | 10.449 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.346512e-11 | 10.362 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.341294e-11 | 10.272 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.369361e-11 | 10.133 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.772916e-11 | 10.109 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.891920e-11 | 10.103 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.035277e-10 | 9.985 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.045375e-10 | 9.981 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.143766e-10 | 9.942 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.148935e-10 | 9.940 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.400262e-10 | 9.854 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.080507e-10 | 9.682 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.329658e-10 | 9.633 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.946030e-10 | 9.531 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.946030e-10 | 9.531 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.610160e-10 | 9.442 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.610160e-10 | 9.442 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.751816e-10 | 9.240 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.751816e-10 | 9.240 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.985561e-10 | 9.156 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.957255e-10 | 9.099 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.330484e-10 | 9.079 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.469362e-10 | 9.072 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.481373e-10 | 9.023 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.137502e-09 | 8.944 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.443186e-09 | 8.841 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.531127e-09 | 8.815 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.633001e-09 | 8.787 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.633001e-09 | 8.787 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.658920e-09 | 8.780 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.768330e-09 | 8.752 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.073233e-09 | 8.683 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.393969e-09 | 8.621 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.683659e-09 | 8.571 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.683659e-09 | 8.571 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.423789e-09 | 8.465 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.515058e-09 | 8.454 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.812797e-09 | 8.419 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.888538e-09 | 8.410 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.533972e-09 | 8.344 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.533972e-09 | 8.344 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.533972e-09 | 8.344 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.533972e-09 | 8.344 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.478186e-09 | 8.349 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.693987e-09 | 8.245 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.415641e-09 | 8.193 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.270512e-09 | 8.138 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.595560e-09 | 8.119 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.736161e-09 | 8.111 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.975599e-09 | 8.098 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.509386e-09 | 8.022 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.701527e-09 | 8.013 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.706777e-09 | 8.013 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.073307e-08 | 7.969 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.073307e-08 | 7.969 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.232171e-08 | 7.909 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.486621e-08 | 7.828 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.487536e-08 | 7.828 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.679361e-08 | 7.775 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.736114e-08 | 7.760 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.783480e-08 | 7.749 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.956025e-08 | 7.709 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.416982e-08 | 7.617 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.470390e-08 | 7.607 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.020880e-08 | 7.520 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.159883e-08 | 7.500 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.020880e-08 | 7.520 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.986231e-08 | 7.525 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.704351e-08 | 7.431 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.560680e-08 | 7.255 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.708666e-08 | 7.243 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.280538e-08 | 7.202 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.612432e-08 | 7.180 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.867442e-08 | 7.163 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.355026e-08 | 7.133 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.384808e-08 | 7.132 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.610717e-08 | 7.119 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.023743e-07 | 6.990 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.614085e-08 | 7.017 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.077598e-07 | 6.968 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.396376e-07 | 6.855 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.422587e-07 | 6.847 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.453568e-07 | 6.838 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.459260e-07 | 6.836 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.501572e-07 | 6.823 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.602932e-07 | 6.795 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.987549e-07 | 6.702 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.987549e-07 | 6.702 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.088874e-07 | 6.680 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.076301e-07 | 6.683 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.152426e-07 | 6.667 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.392851e-07 | 6.621 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.392851e-07 | 6.621 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.653103e-07 | 6.576 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.677895e-07 | 6.572 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.866963e-07 | 6.543 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.900350e-07 | 6.538 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.972286e-07 | 6.527 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.598123e-07 | 6.444 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.608825e-07 | 6.443 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.618582e-07 | 6.441 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.249600e-07 | 6.372 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.423087e-07 | 6.354 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.173240e-07 | 6.286 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.684910e-07 | 6.245 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.849651e-07 | 6.233 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.961699e-07 | 6.225 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.416726e-07 | 6.193 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.860783e-07 | 6.105 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.151510e-07 | 6.039 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.508393e-07 | 6.022 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.965973e-07 | 6.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.965973e-07 | 6.001 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.060345e-06 | 5.975 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.094122e-06 | 5.961 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.194748e-06 | 5.923 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.212882e-06 | 5.916 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.263248e-06 | 5.899 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.289768e-06 | 5.889 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.376165e-06 | 5.861 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.470100e-06 | 5.833 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.797387e-06 | 5.745 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.797387e-06 | 5.745 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.696639e-06 | 5.770 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.611112e-06 | 5.793 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.791735e-06 | 5.747 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.935491e-06 | 5.713 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.961641e-06 | 5.707 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.975235e-06 | 5.704 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.072436e-06 | 5.684 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.139268e-06 | 5.670 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.240425e-06 | 5.650 | 0 | 0 |
| Translation | R-HSA-72766 | 2.287801e-06 | 5.641 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.319486e-06 | 5.635 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.474205e-06 | 5.607 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.478179e-06 | 5.606 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.609420e-06 | 5.583 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.664370e-06 | 5.574 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.770597e-06 | 5.557 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.771748e-06 | 5.557 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.472330e-06 | 5.459 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.478723e-06 | 5.459 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.831820e-06 | 5.417 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.999765e-06 | 5.398 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.363267e-06 | 5.360 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.537864e-06 | 5.343 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.316427e-06 | 5.274 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.530446e-06 | 5.257 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.904071e-06 | 5.229 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.542165e-06 | 5.184 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.754650e-06 | 5.240 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.956545e-06 | 5.225 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.082501e-06 | 5.216 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.548442e-06 | 5.184 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.660998e-06 | 5.176 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.736795e-06 | 5.172 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.906523e-06 | 5.161 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.267058e-06 | 5.139 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.536620e-06 | 5.123 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.794640e-06 | 5.056 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.083639e-06 | 5.042 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.638222e-06 | 5.016 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.722804e-06 | 5.012 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.009375e-05 | 4.996 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.163392e-05 | 4.934 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.310107e-05 | 4.883 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.348949e-05 | 4.870 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.402885e-05 | 4.853 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.503969e-05 | 4.823 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.540745e-05 | 4.812 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.678863e-05 | 4.775 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.795362e-05 | 4.746 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.812224e-05 | 4.742 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.812224e-05 | 4.742 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.812224e-05 | 4.742 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.812224e-05 | 4.742 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.834256e-05 | 4.737 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.893645e-05 | 4.723 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.274972e-05 | 4.643 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.145594e-05 | 4.668 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.209223e-05 | 4.656 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.937410e-05 | 4.713 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.199105e-05 | 4.658 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.199105e-05 | 4.658 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.089224e-05 | 4.680 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.073120e-05 | 4.683 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.361062e-05 | 4.627 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.589485e-05 | 4.587 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.773698e-05 | 4.557 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.032068e-05 | 4.518 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.632559e-05 | 4.440 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.649294e-05 | 4.438 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.018404e-05 | 4.396 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.404241e-05 | 4.267 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.846045e-05 | 4.233 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.060800e-05 | 4.217 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.488586e-05 | 4.188 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.693449e-05 | 4.174 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.832139e-05 | 4.165 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.832139e-05 | 4.165 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.256771e-05 | 4.139 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.414171e-05 | 4.130 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.448722e-05 | 4.128 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.903404e-05 | 4.102 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.132995e-05 | 4.039 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.587785e-05 | 4.018 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.055581e-04 | 3.977 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.153801e-04 | 3.938 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.186884e-04 | 3.926 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.292167e-04 | 3.889 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.292167e-04 | 3.889 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.292167e-04 | 3.889 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.292167e-04 | 3.889 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.493169e-04 | 3.826 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.664615e-04 | 3.779 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.725025e-04 | 3.763 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.755989e-04 | 3.755 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.795946e-04 | 3.746 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.813942e-04 | 3.741 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.930328e-04 | 3.714 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.972783e-04 | 3.705 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.309184e-04 | 3.480 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.789554e-04 | 3.554 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.182885e-04 | 3.497 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.789554e-04 | 3.554 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.922589e-04 | 3.534 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.426600e-04 | 3.465 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.478463e-04 | 3.459 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.640619e-04 | 3.439 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.697735e-04 | 3.432 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.039336e-04 | 3.394 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.224311e-04 | 3.374 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.224311e-04 | 3.374 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.315770e-04 | 3.365 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.315770e-04 | 3.365 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.392035e-04 | 3.357 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.392035e-04 | 3.357 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.426290e-04 | 3.354 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.530470e-04 | 3.344 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.926890e-04 | 3.307 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.992692e-04 | 3.302 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.611724e-04 | 3.251 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.652907e-04 | 3.248 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.668130e-04 | 3.176 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.012565e-04 | 3.154 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.359151e-04 | 3.133 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.423868e-04 | 3.129 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.999844e-04 | 3.097 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.352716e-04 | 3.078 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.057663e-04 | 3.043 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.188082e-04 | 3.037 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.433679e-04 | 3.025 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.433712e-04 | 3.025 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.449235e-04 | 3.025 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.890913e-04 | 3.005 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.028869e-03 | 2.988 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.065602e-03 | 2.972 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.231791e-03 | 2.909 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.413656e-03 | 2.850 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.413656e-03 | 2.850 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.413656e-03 | 2.850 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.413656e-03 | 2.850 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.424484e-03 | 2.846 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.424484e-03 | 2.846 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.428839e-03 | 2.845 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.603800e-03 | 2.795 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.627478e-03 | 2.788 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.838088e-03 | 2.736 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.838088e-03 | 2.736 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.838088e-03 | 2.736 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.861676e-03 | 2.730 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.861676e-03 | 2.730 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.927360e-03 | 2.715 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.986893e-03 | 2.702 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.025066e-03 | 2.694 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.029073e-03 | 2.693 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.083399e-03 | 2.681 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.083399e-03 | 2.681 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.321983e-03 | 2.634 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.333760e-03 | 2.632 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.373714e-03 | 2.625 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.928741e-03 | 2.533 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.436883e-03 | 2.613 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.219434e-03 | 2.492 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.968736e-03 | 2.527 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.968736e-03 | 2.527 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.696384e-03 | 2.569 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.078726e-03 | 2.512 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.318500e-03 | 2.479 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.555073e-03 | 2.449 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.668795e-03 | 2.435 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.877910e-03 | 2.411 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.877910e-03 | 2.411 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.347605e-03 | 2.362 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.347605e-03 | 2.362 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.360100e-03 | 2.361 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.375558e-03 | 2.359 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.552551e-03 | 2.342 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.555941e-03 | 2.341 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.555941e-03 | 2.341 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.638205e-03 | 2.334 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.638205e-03 | 2.334 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.638205e-03 | 2.334 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.030505e-03 | 2.298 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.030505e-03 | 2.298 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.046707e-03 | 2.297 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.046707e-03 | 2.297 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.103544e-03 | 2.292 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.247428e-03 | 2.280 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.247428e-03 | 2.280 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.268891e-03 | 2.278 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.651786e-03 | 2.248 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.651786e-03 | 2.248 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.651786e-03 | 2.248 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.929104e-03 | 2.227 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.095388e-03 | 2.215 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.095388e-03 | 2.215 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.908597e-03 | 2.161 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.166813e-03 | 2.145 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.588959e-03 | 2.120 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.588959e-03 | 2.120 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.588959e-03 | 2.120 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.588959e-03 | 2.120 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.588959e-03 | 2.120 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.250628e-03 | 2.084 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.900293e-03 | 2.051 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.159741e-03 | 2.038 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.576890e-03 | 2.019 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.013193e-02 | 1.994 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.047104e-02 | 1.980 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.147767e-02 | 1.940 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.157244e-02 | 1.937 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.187910e-02 | 1.925 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.187910e-02 | 1.925 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.304190e-02 | 1.885 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.340311e-02 | 1.873 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.340311e-02 | 1.873 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.420409e-02 | 1.848 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.504332e-02 | 1.823 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.504932e-02 | 1.822 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.546730e-02 | 1.811 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.605673e-02 | 1.794 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.628716e-02 | 1.788 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.628716e-02 | 1.788 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.637026e-02 | 1.786 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.637026e-02 | 1.786 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.637026e-02 | 1.786 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.681080e-02 | 1.774 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.747395e-02 | 1.758 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.811737e-02 | 1.742 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.812439e-02 | 1.742 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.812439e-02 | 1.742 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.812439e-02 | 1.742 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.823265e-02 | 1.739 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.854852e-02 | 1.732 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.869972e-02 | 1.728 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.869972e-02 | 1.728 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.896690e-02 | 1.722 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.896690e-02 | 1.722 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.896690e-02 | 1.722 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.896690e-02 | 1.722 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.181887e-02 | 1.661 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.790771e-02 | 1.554 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.285885e-02 | 1.641 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.007641e-02 | 1.522 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.768283e-02 | 1.558 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.415207e-02 | 1.617 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.715092e-02 | 1.566 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.768283e-02 | 1.558 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.752320e-02 | 1.560 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.071508e-02 | 1.684 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.285885e-02 | 1.641 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.513273e-02 | 1.600 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.715092e-02 | 1.566 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.880308e-02 | 1.541 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.219881e-02 | 1.654 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.394069e-02 | 1.621 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.841678e-02 | 1.546 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.257468e-02 | 1.646 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.257468e-02 | 1.646 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.753818e-02 | 1.560 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.556274e-02 | 1.592 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.273276e-02 | 1.643 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.880308e-02 | 1.541 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.054135e-02 | 1.687 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.033390e-02 | 1.692 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.056239e-02 | 1.515 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.165700e-02 | 1.500 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.177706e-02 | 1.498 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.230266e-02 | 1.491 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.395865e-02 | 1.469 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.465941e-02 | 1.460 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.497534e-02 | 1.456 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.497534e-02 | 1.456 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.497534e-02 | 1.456 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.555474e-02 | 1.449 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.555474e-02 | 1.449 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.606765e-02 | 1.443 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.767084e-02 | 1.424 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.770950e-02 | 1.424 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.859482e-02 | 1.413 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.859482e-02 | 1.413 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.182500e-02 | 1.379 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.182500e-02 | 1.379 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.182500e-02 | 1.379 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.182500e-02 | 1.379 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.222419e-02 | 1.374 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.335959e-02 | 1.363 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.335959e-02 | 1.363 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.359911e-02 | 1.361 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.359911e-02 | 1.361 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.431628e-02 | 1.353 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.478411e-02 | 1.349 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.624047e-02 | 1.335 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.624047e-02 | 1.335 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.667415e-02 | 1.331 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.667415e-02 | 1.331 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.789363e-02 | 1.320 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.813072e-02 | 1.318 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.813072e-02 | 1.318 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.897507e-02 | 1.310 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.897507e-02 | 1.310 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.956844e-02 | 1.305 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.956844e-02 | 1.305 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.956844e-02 | 1.305 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.180310e-02 | 1.286 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.265051e-02 | 1.279 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.265051e-02 | 1.279 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.265051e-02 | 1.279 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.472465e-02 | 1.262 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.641732e-02 | 1.249 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.762582e-02 | 1.239 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.762582e-02 | 1.239 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.773973e-02 | 1.239 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.773973e-02 | 1.239 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.778191e-02 | 1.238 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.778191e-02 | 1.238 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.778191e-02 | 1.238 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.778191e-02 | 1.238 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.778191e-02 | 1.238 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.778191e-02 | 1.238 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.897545e-02 | 1.229 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.978894e-02 | 1.223 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 6.015687e-02 | 1.221 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.084823e-02 | 1.216 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.171430e-02 | 1.210 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 6.231371e-02 | 1.205 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 6.231371e-02 | 1.205 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 6.231371e-02 | 1.205 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 6.231371e-02 | 1.205 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.285599e-02 | 1.202 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.419505e-02 | 1.192 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.642800e-02 | 1.178 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.642800e-02 | 1.178 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.821227e-02 | 1.166 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.821227e-02 | 1.166 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.073191e-02 | 1.150 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.100882e-02 | 1.149 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.262950e-02 | 1.139 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.421129e-02 | 1.130 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.547121e-02 | 1.122 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.931129e-02 | 1.101 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.961073e-02 | 1.099 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.961073e-02 | 1.099 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.961073e-02 | 1.099 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.961073e-02 | 1.099 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.961073e-02 | 1.099 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.102210e-02 | 1.091 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.419503e-02 | 1.075 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.419503e-02 | 1.075 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 9.200168e-02 | 1.036 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 9.200168e-02 | 1.036 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 9.200168e-02 | 1.036 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 9.200168e-02 | 1.036 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 9.200168e-02 | 1.036 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.207515e-01 | 0.918 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.207515e-01 | 0.918 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.207515e-01 | 0.918 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.207515e-01 | 0.918 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.207515e-01 | 0.918 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.207515e-01 | 0.918 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.485926e-01 | 0.828 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.487785e-02 | 1.071 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.487785e-02 | 1.071 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.461594e-02 | 1.024 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.461594e-02 | 1.024 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.046552e-01 | 0.980 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.149668e-01 | 0.939 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.255236e-01 | 0.901 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.255236e-01 | 0.901 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.255236e-01 | 0.901 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.255236e-01 | 0.901 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.362998e-01 | 0.866 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.362998e-01 | 0.866 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.362998e-01 | 0.866 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.362998e-01 | 0.866 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.472710e-01 | 0.832 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.560004e-02 | 1.068 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.584141e-01 | 0.800 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.812803e-02 | 1.008 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.812803e-02 | 1.008 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.697074e-01 | 0.770 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.848576e-02 | 1.007 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.034849e-01 | 0.985 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.010899e-01 | 0.995 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.532814e-01 | 0.815 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.046539e-01 | 0.980 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.323488e-01 | 0.878 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.274694e-01 | 0.895 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.301366e-01 | 0.886 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.251999e-01 | 0.902 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.357795e-01 | 0.867 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.461594e-02 | 1.024 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.697074e-01 | 0.770 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.773722e-02 | 1.010 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.046552e-01 | 0.980 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.149668e-01 | 0.939 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.191552e-01 | 0.924 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.473548e-01 | 0.832 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.021633e-01 | 0.991 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.678014e-02 | 1.062 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.207515e-01 | 0.918 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.485926e-01 | 0.828 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.255236e-01 | 0.901 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.584141e-01 | 0.800 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.181966e-01 | 0.927 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.360290e-02 | 1.029 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.622638e-01 | 0.790 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.301366e-01 | 0.886 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.228704e-01 | 0.911 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.021633e-01 | 0.991 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.186827e-01 | 0.926 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.597584e-02 | 1.066 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.626671e-01 | 0.789 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.154671e-01 | 0.938 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.943580e-02 | 1.002 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.555946e-01 | 0.808 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 9.200168e-02 | 1.036 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.251999e-01 | 0.902 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.546008e-01 | 0.811 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.546008e-01 | 0.811 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.138221e-01 | 0.944 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.320233e-01 | 0.879 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.383147e-01 | 0.859 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.485926e-01 | 0.828 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 1.472710e-01 | 0.832 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.095539e-01 | 0.960 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.053323e-02 | 1.043 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.584189e-02 | 1.018 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.697074e-01 | 0.770 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.584189e-02 | 1.018 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.487785e-02 | 1.071 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.362998e-01 | 0.866 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.622638e-01 | 0.790 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.042978e-01 | 0.982 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.251999e-01 | 0.902 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.425471e-01 | 0.846 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.897478e-02 | 1.004 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.425471e-01 | 0.846 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.425471e-01 | 0.846 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.207515e-01 | 0.918 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.487785e-02 | 1.071 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.046552e-01 | 0.980 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.396365e-01 | 0.855 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.470561e-01 | 0.833 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.470561e-01 | 0.833 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.546008e-01 | 0.811 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.883859e-02 | 1.051 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.120595e-01 | 0.951 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.224429e-01 | 0.912 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.697074e-01 | 0.770 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.360290e-02 | 1.029 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.360290e-02 | 1.029 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.095539e-01 | 0.960 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.146634e-02 | 1.039 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.473548e-01 | 0.832 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.515999e-01 | 0.819 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.566420e-01 | 0.805 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.010899e-01 | 0.995 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.370226e-01 | 0.863 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.461594e-02 | 1.024 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.536432e-01 | 0.813 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.183506e-01 | 0.927 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.362998e-01 | 0.866 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.519621e-02 | 1.070 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.274694e-01 | 0.895 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.459635e-02 | 1.024 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.622638e-01 | 0.790 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.472710e-01 | 0.832 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 1.465458e-01 | 0.834 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.301366e-01 | 0.886 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.700384e-01 | 0.769 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.700384e-01 | 0.769 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.700384e-01 | 0.769 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.700384e-01 | 0.769 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.701756e-01 | 0.769 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.715800e-01 | 0.766 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.755539e-01 | 0.756 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.755539e-01 | 0.756 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.755539e-01 | 0.756 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.755539e-01 | 0.756 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.755539e-01 | 0.756 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.755539e-01 | 0.756 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.778420e-01 | 0.750 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.811301e-01 | 0.742 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.811301e-01 | 0.742 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.811301e-01 | 0.742 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.811301e-01 | 0.742 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.850695e-01 | 0.733 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.858951e-01 | 0.731 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.858951e-01 | 0.731 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.858951e-01 | 0.731 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.858951e-01 | 0.731 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.858951e-01 | 0.731 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.858951e-01 | 0.731 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.879458e-01 | 0.726 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.882254e-01 | 0.725 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.896114e-01 | 0.722 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.926628e-01 | 0.715 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 1.926628e-01 | 0.715 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.926628e-01 | 0.715 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.926628e-01 | 0.715 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.937455e-01 | 0.713 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.939641e-01 | 0.712 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.939641e-01 | 0.712 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.939641e-01 | 0.712 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.985135e-01 | 0.702 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.992825e-01 | 0.701 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.016629e-01 | 0.695 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.016629e-01 | 0.695 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.016629e-01 | 0.695 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.016629e-01 | 0.695 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.016629e-01 | 0.695 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.016629e-01 | 0.695 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.016629e-01 | 0.695 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.016629e-01 | 0.695 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.016629e-01 | 0.695 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.016629e-01 | 0.695 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.016629e-01 | 0.695 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.016629e-01 | 0.695 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.021181e-01 | 0.694 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.021181e-01 | 0.694 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.021181e-01 | 0.694 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.021181e-01 | 0.694 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.042872e-01 | 0.690 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.042872e-01 | 0.690 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.103506e-01 | 0.677 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.103506e-01 | 0.677 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.103506e-01 | 0.677 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.103506e-01 | 0.677 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.125139e-01 | 0.673 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.159859e-01 | 0.666 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.159859e-01 | 0.666 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.159859e-01 | 0.666 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.194004e-01 | 0.659 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.219467e-01 | 0.654 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.269467e-01 | 0.644 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.269467e-01 | 0.644 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.269467e-01 | 0.644 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.269467e-01 | 0.644 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.269467e-01 | 0.644 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.269467e-01 | 0.644 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.269467e-01 | 0.644 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.269467e-01 | 0.644 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.269467e-01 | 0.644 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.269467e-01 | 0.644 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.269467e-01 | 0.644 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.269467e-01 | 0.644 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.269467e-01 | 0.644 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.270263e-01 | 0.644 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.277320e-01 | 0.643 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.277427e-01 | 0.643 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.277427e-01 | 0.643 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.277427e-01 | 0.643 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.354571e-01 | 0.628 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.354571e-01 | 0.628 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.354571e-01 | 0.628 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.372364e-01 | 0.625 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.395421e-01 | 0.621 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.395421e-01 | 0.621 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.397777e-01 | 0.620 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.397777e-01 | 0.620 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.439419e-01 | 0.613 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.439419e-01 | 0.613 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.439419e-01 | 0.613 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.439419e-01 | 0.613 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.439419e-01 | 0.613 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.444888e-01 | 0.612 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.453431e-01 | 0.610 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.453431e-01 | 0.610 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.510364e-01 | 0.600 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.510364e-01 | 0.600 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.513697e-01 | 0.600 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.513697e-01 | 0.600 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.513697e-01 | 0.600 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.513697e-01 | 0.600 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.513697e-01 | 0.600 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.514312e-01 | 0.600 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.514312e-01 | 0.600 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.514312e-01 | 0.600 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.514312e-01 | 0.600 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.514312e-01 | 0.600 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.514312e-01 | 0.600 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.514312e-01 | 0.600 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.514312e-01 | 0.600 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.514312e-01 | 0.600 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.514312e-01 | 0.600 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.514312e-01 | 0.600 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.514312e-01 | 0.600 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.592446e-01 | 0.586 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.592446e-01 | 0.586 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.592446e-01 | 0.586 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.632120e-01 | 0.580 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.632120e-01 | 0.580 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.632120e-01 | 0.580 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.632120e-01 | 0.580 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.632120e-01 | 0.580 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.632120e-01 | 0.580 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.632956e-01 | 0.580 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.648191e-01 | 0.577 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.650002e-01 | 0.577 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.696617e-01 | 0.569 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.750561e-01 | 0.561 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.750561e-01 | 0.561 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.750561e-01 | 0.561 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.751417e-01 | 0.560 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.751417e-01 | 0.560 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.751417e-01 | 0.560 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.751417e-01 | 0.560 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.751417e-01 | 0.560 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.751417e-01 | 0.560 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 2.751417e-01 | 0.560 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.751417e-01 | 0.560 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.754024e-01 | 0.560 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.754024e-01 | 0.560 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.754275e-01 | 0.560 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.791033e-01 | 0.554 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.868901e-01 | 0.542 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.868901e-01 | 0.542 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.868901e-01 | 0.542 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.868901e-01 | 0.542 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 2.869740e-01 | 0.542 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.884781e-01 | 0.540 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.938319e-01 | 0.532 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.956637e-01 | 0.529 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 2.981026e-01 | 0.526 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 2.981026e-01 | 0.526 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.981026e-01 | 0.526 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.981026e-01 | 0.526 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.981026e-01 | 0.526 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.981026e-01 | 0.526 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.981026e-01 | 0.526 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 2.981026e-01 | 0.526 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.981026e-01 | 0.526 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 2.981026e-01 | 0.526 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.987028e-01 | 0.525 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.987028e-01 | 0.525 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.004662e-01 | 0.522 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.035311e-01 | 0.518 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.043692e-01 | 0.517 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.085848e-01 | 0.511 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.104838e-01 | 0.508 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.104838e-01 | 0.508 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.104838e-01 | 0.508 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.130854e-01 | 0.504 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.148129e-01 | 0.502 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.203375e-01 | 0.494 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.203375e-01 | 0.494 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.203375e-01 | 0.494 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.203375e-01 | 0.494 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.203375e-01 | 0.494 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.203375e-01 | 0.494 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.203375e-01 | 0.494 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.203375e-01 | 0.494 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.203375e-01 | 0.494 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.222231e-01 | 0.492 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.222231e-01 | 0.492 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.222231e-01 | 0.492 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.339117e-01 | 0.476 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.339117e-01 | 0.476 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.339117e-01 | 0.476 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.339117e-01 | 0.476 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.368540e-01 | 0.473 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.392514e-01 | 0.469 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.392514e-01 | 0.469 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.418694e-01 | 0.466 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.418694e-01 | 0.466 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.418694e-01 | 0.466 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.418694e-01 | 0.466 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.418694e-01 | 0.466 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.418694e-01 | 0.466 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.418694e-01 | 0.466 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.418694e-01 | 0.466 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.418694e-01 | 0.466 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.418694e-01 | 0.466 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.418694e-01 | 0.466 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 3.418694e-01 | 0.466 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.418694e-01 | 0.466 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.418694e-01 | 0.466 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.418694e-01 | 0.466 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.419642e-01 | 0.466 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.495171e-01 | 0.457 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.563566e-01 | 0.448 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.566655e-01 | 0.448 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.571029e-01 | 0.447 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.571029e-01 | 0.447 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.571029e-01 | 0.447 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.581116e-01 | 0.446 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.627204e-01 | 0.440 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.627204e-01 | 0.440 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.627204e-01 | 0.440 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 3.627204e-01 | 0.440 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 3.627204e-01 | 0.440 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.627204e-01 | 0.440 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.627204e-01 | 0.440 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.627204e-01 | 0.440 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.627204e-01 | 0.440 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.627204e-01 | 0.440 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.627204e-01 | 0.440 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.627204e-01 | 0.440 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.653381e-01 | 0.437 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.653381e-01 | 0.437 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.653510e-01 | 0.437 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.685902e-01 | 0.433 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.694362e-01 | 0.432 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 3.740169e-01 | 0.427 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.799961e-01 | 0.420 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.799961e-01 | 0.420 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.799961e-01 | 0.420 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.799961e-01 | 0.420 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.799961e-01 | 0.420 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.799961e-01 | 0.420 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.826594e-01 | 0.417 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.826594e-01 | 0.417 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 3.829120e-01 | 0.417 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.829120e-01 | 0.417 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.829120e-01 | 0.417 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.829120e-01 | 0.417 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.829120e-01 | 0.417 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.829120e-01 | 0.417 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 3.829120e-01 | 0.417 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.829120e-01 | 0.417 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 3.829120e-01 | 0.417 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.829120e-01 | 0.417 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.829120e-01 | 0.417 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.829120e-01 | 0.417 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.829120e-01 | 0.417 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.829120e-01 | 0.417 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.912748e-01 | 0.408 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.913140e-01 | 0.407 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.929177e-01 | 0.406 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.929177e-01 | 0.406 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.929177e-01 | 0.406 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.941821e-01 | 0.404 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.024651e-01 | 0.395 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.024651e-01 | 0.395 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.024651e-01 | 0.395 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.024651e-01 | 0.395 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.024651e-01 | 0.395 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.024651e-01 | 0.395 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.024651e-01 | 0.395 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.024651e-01 | 0.395 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.024651e-01 | 0.395 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.024651e-01 | 0.395 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.024651e-01 | 0.395 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.024651e-01 | 0.395 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.025383e-01 | 0.395 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.025383e-01 | 0.395 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.025383e-01 | 0.395 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.025383e-01 | 0.395 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 4.025383e-01 | 0.395 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.025383e-01 | 0.395 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.025383e-01 | 0.395 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.025383e-01 | 0.395 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.025383e-01 | 0.395 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.065765e-01 | 0.391 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.084107e-01 | 0.389 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.117705e-01 | 0.385 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.130626e-01 | 0.384 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.136634e-01 | 0.383 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.155775e-01 | 0.381 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.169247e-01 | 0.380 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.213998e-01 | 0.375 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.213998e-01 | 0.375 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.213998e-01 | 0.375 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.213998e-01 | 0.375 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.213998e-01 | 0.375 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.213998e-01 | 0.375 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.246844e-01 | 0.372 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.246844e-01 | 0.372 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.246844e-01 | 0.372 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.370169e-01 | 0.360 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.380738e-01 | 0.358 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.397356e-01 | 0.357 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.397356e-01 | 0.357 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.397356e-01 | 0.357 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.397356e-01 | 0.357 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.397356e-01 | 0.357 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.397356e-01 | 0.357 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.397356e-01 | 0.357 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.397356e-01 | 0.357 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.397356e-01 | 0.357 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.397356e-01 | 0.357 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.463963e-01 | 0.350 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.463963e-01 | 0.350 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.463963e-01 | 0.350 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.504916e-01 | 0.346 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.549611e-01 | 0.342 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.549611e-01 | 0.342 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.566740e-01 | 0.340 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.570792e-01 | 0.340 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.574914e-01 | 0.340 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.574914e-01 | 0.340 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.574914e-01 | 0.340 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.574914e-01 | 0.340 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.574914e-01 | 0.340 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.574914e-01 | 0.340 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.574914e-01 | 0.340 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.574914e-01 | 0.340 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.574914e-01 | 0.340 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.574914e-01 | 0.340 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.574914e-01 | 0.340 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.574914e-01 | 0.340 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.574914e-01 | 0.340 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.574914e-01 | 0.340 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.574914e-01 | 0.340 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.581212e-01 | 0.339 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.588348e-01 | 0.338 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.676420e-01 | 0.330 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.676420e-01 | 0.330 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.676420e-01 | 0.330 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.720414e-01 | 0.326 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 4.746855e-01 | 0.324 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.746855e-01 | 0.324 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.746855e-01 | 0.324 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.746855e-01 | 0.324 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.746855e-01 | 0.324 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.746855e-01 | 0.324 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 4.746855e-01 | 0.324 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.746855e-01 | 0.324 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.780816e-01 | 0.320 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.780816e-01 | 0.320 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.780816e-01 | 0.320 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.780816e-01 | 0.320 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.789517e-01 | 0.320 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.883952e-01 | 0.311 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.883952e-01 | 0.311 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.883952e-01 | 0.311 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.913358e-01 | 0.309 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.913358e-01 | 0.309 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.913358e-01 | 0.309 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.913358e-01 | 0.309 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 4.913358e-01 | 0.309 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.913358e-01 | 0.309 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 4.913358e-01 | 0.309 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.913358e-01 | 0.309 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 4.913358e-01 | 0.309 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.913358e-01 | 0.309 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.914154e-01 | 0.309 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.985803e-01 | 0.302 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.985803e-01 | 0.302 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.985803e-01 | 0.302 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.993396e-01 | 0.302 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.074593e-01 | 0.295 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.074593e-01 | 0.295 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.074593e-01 | 0.295 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.074593e-01 | 0.295 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.074593e-01 | 0.295 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.074593e-01 | 0.295 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.074593e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.086347e-01 | 0.294 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.100264e-01 | 0.292 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.129458e-01 | 0.290 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.139863e-01 | 0.289 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.185565e-01 | 0.285 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.185565e-01 | 0.285 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.230726e-01 | 0.281 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.230726e-01 | 0.281 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.230726e-01 | 0.281 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.230726e-01 | 0.281 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.230726e-01 | 0.281 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.230726e-01 | 0.281 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.230726e-01 | 0.281 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.230726e-01 | 0.281 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.262578e-01 | 0.279 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.283440e-01 | 0.277 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.283440e-01 | 0.277 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.378316e-01 | 0.269 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.379957e-01 | 0.269 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.379957e-01 | 0.269 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.379957e-01 | 0.269 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.381919e-01 | 0.269 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.381919e-01 | 0.269 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.381919e-01 | 0.269 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.381919e-01 | 0.269 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.381919e-01 | 0.269 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.381919e-01 | 0.269 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.381919e-01 | 0.269 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.381919e-01 | 0.269 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.381919e-01 | 0.269 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 5.381919e-01 | 0.269 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.381919e-01 | 0.269 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.383882e-01 | 0.269 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.475103e-01 | 0.262 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.528329e-01 | 0.257 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.528329e-01 | 0.257 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.528329e-01 | 0.257 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 5.528329e-01 | 0.257 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.528329e-01 | 0.257 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.609248e-01 | 0.251 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.661248e-01 | 0.247 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.670105e-01 | 0.246 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.670105e-01 | 0.246 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.670105e-01 | 0.246 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.670105e-01 | 0.246 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.670105e-01 | 0.246 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.670105e-01 | 0.246 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.670105e-01 | 0.246 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.670105e-01 | 0.246 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 5.670105e-01 | 0.246 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.670105e-01 | 0.246 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.670105e-01 | 0.246 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 5.670105e-01 | 0.246 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.722769e-01 | 0.242 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.752231e-01 | 0.240 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.752231e-01 | 0.240 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.800901e-01 | 0.237 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.807395e-01 | 0.236 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.807395e-01 | 0.236 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.807395e-01 | 0.236 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.807395e-01 | 0.236 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.807395e-01 | 0.236 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.807395e-01 | 0.236 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 5.807395e-01 | 0.236 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.807395e-01 | 0.236 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.807395e-01 | 0.236 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.807395e-01 | 0.236 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.827836e-01 | 0.234 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 5.899148e-01 | 0.229 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.940339e-01 | 0.226 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.940339e-01 | 0.226 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.940339e-01 | 0.226 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.940339e-01 | 0.226 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.940339e-01 | 0.226 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.940339e-01 | 0.226 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.940339e-01 | 0.226 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.000798e-01 | 0.222 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.069076e-01 | 0.217 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.069076e-01 | 0.217 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.069076e-01 | 0.217 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.069076e-01 | 0.217 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.102156e-01 | 0.215 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.102156e-01 | 0.215 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.186132e-01 | 0.209 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.193739e-01 | 0.208 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.193739e-01 | 0.208 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.193739e-01 | 0.208 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.193739e-01 | 0.208 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.193739e-01 | 0.208 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.193739e-01 | 0.208 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.193739e-01 | 0.208 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.268710e-01 | 0.203 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.314455e-01 | 0.200 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.314455e-01 | 0.200 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 6.314455e-01 | 0.200 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.314455e-01 | 0.200 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 6.314716e-01 | 0.200 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.322266e-01 | 0.199 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.322266e-01 | 0.199 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.349894e-01 | 0.197 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.349894e-01 | 0.197 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.387852e-01 | 0.195 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.429690e-01 | 0.192 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.429690e-01 | 0.192 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.431349e-01 | 0.192 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.431349e-01 | 0.192 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 6.431349e-01 | 0.192 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.431349e-01 | 0.192 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.504818e-01 | 0.187 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.508104e-01 | 0.187 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.508104e-01 | 0.187 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.544544e-01 | 0.184 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.544544e-01 | 0.184 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.544544e-01 | 0.184 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.544544e-01 | 0.184 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.544544e-01 | 0.184 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.544544e-01 | 0.184 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.544544e-01 | 0.184 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.544544e-01 | 0.184 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.585143e-01 | 0.181 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.654154e-01 | 0.177 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 6.654154e-01 | 0.177 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.654154e-01 | 0.177 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.654154e-01 | 0.177 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.654154e-01 | 0.177 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.654154e-01 | 0.177 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.691967e-01 | 0.174 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.732409e-01 | 0.172 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.735130e-01 | 0.172 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.735130e-01 | 0.172 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 6.760294e-01 | 0.170 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.760294e-01 | 0.170 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.760294e-01 | 0.170 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.760294e-01 | 0.170 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.760294e-01 | 0.170 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 6.760294e-01 | 0.170 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.760294e-01 | 0.170 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.808097e-01 | 0.167 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.812606e-01 | 0.167 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.863073e-01 | 0.163 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.863073e-01 | 0.163 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.863073e-01 | 0.163 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.863073e-01 | 0.163 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.863073e-01 | 0.163 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.863073e-01 | 0.163 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.863073e-01 | 0.163 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.962598e-01 | 0.157 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.962598e-01 | 0.157 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.962598e-01 | 0.157 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.019025e-01 | 0.154 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.058971e-01 | 0.151 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.058971e-01 | 0.151 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.152292e-01 | 0.146 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.152292e-01 | 0.146 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.152292e-01 | 0.146 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.152292e-01 | 0.146 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.152292e-01 | 0.146 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.154808e-01 | 0.145 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.218247e-01 | 0.142 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.242657e-01 | 0.140 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.242657e-01 | 0.140 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.242657e-01 | 0.140 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.251369e-01 | 0.140 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.282115e-01 | 0.138 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.330160e-01 | 0.135 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.330160e-01 | 0.135 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.330160e-01 | 0.135 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 7.330160e-01 | 0.135 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 7.406128e-01 | 0.130 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.414891e-01 | 0.130 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.414891e-01 | 0.130 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.414891e-01 | 0.130 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.414891e-01 | 0.130 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 7.466302e-01 | 0.127 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.496939e-01 | 0.125 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.554894e-01 | 0.122 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.576387e-01 | 0.121 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.576387e-01 | 0.121 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 7.576387e-01 | 0.121 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.613862e-01 | 0.118 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.639681e-01 | 0.117 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.639681e-01 | 0.117 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.648168e-01 | 0.116 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.653318e-01 | 0.116 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.727812e-01 | 0.112 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.727812e-01 | 0.112 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.727812e-01 | 0.112 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.727812e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.799945e-01 | 0.108 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.799945e-01 | 0.108 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 7.799945e-01 | 0.108 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.799945e-01 | 0.108 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.799945e-01 | 0.108 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 7.799945e-01 | 0.108 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.799945e-01 | 0.108 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.802677e-01 | 0.108 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.848569e-01 | 0.105 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.869793e-01 | 0.104 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.871020e-01 | 0.104 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.927926e-01 | 0.101 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.937427e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.937427e-01 | 0.100 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.987139e-01 | 0.098 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.002918e-01 | 0.097 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.002918e-01 | 0.097 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.035157e-01 | 0.095 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.066334e-01 | 0.093 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.066334e-01 | 0.093 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.077247e-01 | 0.093 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.127739e-01 | 0.090 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.127739e-01 | 0.090 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.187198e-01 | 0.087 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.187198e-01 | 0.087 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.187198e-01 | 0.087 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.209517e-01 | 0.086 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.244773e-01 | 0.084 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.244773e-01 | 0.084 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.244773e-01 | 0.084 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.244773e-01 | 0.084 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.244773e-01 | 0.084 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.276693e-01 | 0.082 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.341969e-01 | 0.079 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.354504e-01 | 0.078 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.399827e-01 | 0.076 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.399827e-01 | 0.076 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.406774e-01 | 0.075 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.439069e-01 | 0.074 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.457387e-01 | 0.073 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.517913e-01 | 0.070 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.521093e-01 | 0.070 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.587447e-01 | 0.066 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.599799e-01 | 0.066 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.653939e-01 | 0.063 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.653939e-01 | 0.063 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.656703e-01 | 0.063 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.687372e-01 | 0.061 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.690152e-01 | 0.061 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 8.729086e-01 | 0.059 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.729086e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.729086e-01 | 0.059 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.769477e-01 | 0.057 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.808587e-01 | 0.055 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.846457e-01 | 0.053 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.918629e-01 | 0.050 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.953007e-01 | 0.048 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 8.986294e-01 | 0.046 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.018525e-01 | 0.045 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.109208e-01 | 0.041 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.109208e-01 | 0.041 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.109208e-01 | 0.041 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.127361e-01 | 0.040 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.137538e-01 | 0.039 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.153132e-01 | 0.038 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.191528e-01 | 0.037 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.191528e-01 | 0.037 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.196172e-01 | 0.036 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.217244e-01 | 0.035 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.242144e-01 | 0.034 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.266253e-01 | 0.033 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.266253e-01 | 0.033 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.266253e-01 | 0.033 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.330996e-01 | 0.030 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.355274e-01 | 0.029 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.395656e-01 | 0.027 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.395656e-01 | 0.027 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.395656e-01 | 0.027 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.433513e-01 | 0.025 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.533463e-01 | 0.021 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.590111e-01 | 0.018 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.639892e-01 | 0.016 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.683638e-01 | 0.014 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.693352e-01 | 0.014 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.717535e-01 | 0.012 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.731791e-01 | 0.012 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.753810e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.758721e-01 | 0.011 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.767023e-01 | 0.010 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.839805e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.844916e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.846443e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.854655e-01 | 0.006 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.873814e-01 | 0.006 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.890003e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.894923e-01 | 0.005 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.904672e-01 | 0.004 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.930522e-01 | 0.003 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.945115e-01 | 0.002 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.959035e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.971493e-01 | 0.001 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.974851e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.986004e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.986887e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.989442e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.993240e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.993388e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.995531e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.997750e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998550e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999436e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999820e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999868e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999963e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999966e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |